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Abstract The oxidative susceptibility of plasma obtained from
rats after intragastric administration of quercetin was studied to
know whether or not quercetin acts as an in vivo antioxidant
after metabolic conversion. Quercetin was raised in the rat blood
plasma essentially as glucuronide and/or sulfate conjugates. The
plasma obtained from rats after quercetin administration was
more resistant against copper sulfate-induced lipid peroxidation
than the control plasma on the basis of the accumulation of
cholesteryl ester hydroperoxides and the consumption of K-
tocopherol. The results strongly suggest that some conjugated
metabolites of quercetin act as effective antioxidants when
plasma is subject to metal ion-induced lipid peroxidation.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Flavonoids are polyphenolic compounds that occur in a
variety of foods and beverages from vegetable origin [1,2].
Among £avonoids, quercetin is the major representative of
the £avonol subclass. In vitro, it has been shown that quer-
cetin is a strong antioxidant with peroxyl radical-scavenging
activity [3^5] and suppresses oxidation of low-density lipopro-
tein (LDL) [6,7]. Much evidence has implicated the role of
oxidized LDL in atherogenesis [8,9]. Epidemiological studies
showed that consumption of certain £avonoids including
quercetin was correlated with decreasing risk of coronary ar-
tery disease mortality [10^12].
After some negative early reports about uptake of quercetin
in man [13,14], recent studies have shown good absorption of
quercetin from onions [15,16] and from normal diet [17] by
human beings. In addition, Manach et al. [18^20] have dem-
onstrated the uptake of quercetin and its metabolic conversion
to conjugated and methylated derivatives in rats. In the pre-
ceding study, we succeeded in the determination of conjugated
metabolites of quercetin in rat plasma by using a combination
of enzymatic hydrolysis and HPLC analysis (Piskula, M. and
Terao, J., unpublished). However, there is little evidence on
the antioxidative ability of conjugated metabolites of querce-
tin. The present study was designed as an attempt to clarify
this topic by measuring the susceptibility to lipid peroxidation
of plasma obtained from rats after intragastric administration
of quercetin.
2. Materials and methods
2.1. Materials
Quercetin (3,3P,4P,5,7-pentahydroxy£avone), L-glucuronidase type
VII-A, sulfatase type VIII and sulfatase type H-5 were obtained
from Sigma Chemical Co. (St. Louis, MO, USA). 2,2P-Azobis(2-ami-
dinopropane) dihydrochloride (AAPH) was purchased from Wako
Chemicals Co., (Tokyo, Japan). All solvents used were of HPLC
grade (Nacalai Tesque, Inc., Kyoto, Japan).
2.2. Animals and quercetin administration
Twenty-four male Wistar rats, weighing 195^210 g were obtained
from Charles River Japan Inc. (Atsugi, Japan). The animals were
randomly divided into three groups of eight rats. All groups of ani-
mals were maintained in a room at 23‡C under 12 h dark/light cycling.
Water and regular chow were supplied ad libitum. Quercetin (2 or
10 mg/200 g weight body) was dissolved in 2 ml of propylene glycol
and then administered intragastrically by stomach intubation to two
groups of 12^15 h fasting rats. Control rats (n=8) were administered
with only vehicle (propylene glycol). No side e¡ects were observed
during the experimental time period. One h and 6 h after administra-
tion, four rats from each group were anesthesized by diethyl ether, the
abdomen wall was opened and blood was collected from the abdomi-
nal aorta into heparinized tubes. Plasma was isolated by centrifuga-
tion at 4‡C (1000Ug for 20 min) and used immediately for experi-
ments or stored at 320‡C for no more than one week.
2.3. Determination of quercetin conjugated metabolites in rat plasma
For the determination of quercetin glucuronides, plasma aliquots
(50 Wl) from rats administered with 2 or 10 mg quercetin were mixed
with 50 units of L-glucuronidase solution in 0.2 M acetate bu¡er (pH
5.0) and incubated at 37‡C under agitation for 2 h. Plasma was mixed
with sulfatase type VIII (25 U) in 0.2 M acetate bu¡er (pH 5.0) at
37‡C for 4 h for the determination of sulfate conjugates. To inhibit
the L-glucuronidase contaminant activity present in the sulfatase prep-
aration (6 3 U), D-saccharic acid 1,4-lactone (4 mg/ml) was added.
For sulfoglucuronide conjugates, plasma was incubated with 25 U
sulfatase type H-5 in 0.2 M acetate bu¡er pH 5.0 at 37‡C in water
shaking bath for 45 min. This sulfatase preparation revealed substan-
tial L-glucuronidase activity (500 U of enzyme). Quercetin containing
plasma released by enzymatic hydrolysis (50 Wl) was extracted with
50 Wl of 0.2 M acetate bu¡er and 950 Wl of methanol:acetic acid
(100:5, v/v). The mixture was vortexed and sonicated for 30 s and
centrifuged for 5 min at 5000Ug. The supernatant was diluted with
equivalent volume of water and a resulting aliquot was injected on an
HPLC column (TSK gel ODS-80TS, 5 Wm, 150U4.6 mm, TOSOH,
Japan). The £ow rate of the mobile phase, composed of methanol/
water/acetic acid (55/43/2, v/v/v) containing 50 mM lithium acetate,
was 0.9 ml/min. Elute was monitored with amperometric electrochem-
ical detector (ICA-3062, TOA, Japan) set at 6.4 nA/F.S and working
potential at +800 mV. Experiments with quercetin spiked plasma
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showed that this procedure ensures approximately 95% of quercetin
recovery. Quantitative determination was done by external standard
method. It was veri¢ed that the detector response was linear with
standards up to 20 WM. When necessary, samples were diluted with
chloroform/water/acetic acid (50/50/3, v/v/v) prior to HPLC injec-
tion.
2.4. Isolation and mass spectrometry of quercetin metabolites
Plasma (4.0 ml) was obtained from four rats after 2 h oral admin-
istration of quercetin (10 mg/200 g body weight in 2.0 ml propylene
glycol) by the same procedure as described above, and then mixed
with 16 ml of methanol vigorously. The mixture was then centrifuged
at 2000Ug for 20 min to obtain methanol extract. The extract was
washed with 32 ml of water and 24 ml of chloroform. After centrifu-
gation, the methanol-water layer was evaporated in a rotary evapo-
rator and redissolved with 4.0 ml of water. Water fraction was then
applied to solid-phase-extract cartridge (Mega Bond Elut C18, Var-
ian, CA, USA). The cartridge was treated with 6.0 ml of methanol
and 6.0 ml of water. After the sample application and washing with
6.0 ml of water, quercetin metabolites were eluted with 6.0 ml of 30%
methanol. After evaporation, the metabolites were hydrolyzed by
4.0 ml of 2 N HCl at 90‡C for 2 h. The solution was neutralized by
NaOH and was applied to solid-phase-extract cartridge with the same
procedure as described above, except for 90% methanol instead of
30% methanol for the elution of hydrolyzed metabolites. The elute
was concentrated in vacuo and then subject to LC-MS analysis (M-
1200AP Mass spectrometer, Hitachi, Japan), which was connected to
L-7000 HPLC system (Hitachi). The column, YMC-Pack A-312 S-5
ODS, 6U150 mm (YMC, Japan) was used and eluted with methanol/
water/acetic acid (60:40:0.2, v/v/v) at £ow rate of 0.9 ml/min. The LC-
MS conditions were as follows; nebulizer temperature at 200‡C, dis-
solver temperature at 400‡C, apparatus-1 and -2 temperature of
120‡C.
2.5. Oxidation of rat plasma pool induced by copper sulfate
Plasma from propylene glycol (control) or quercetin solution ad-
ministered rats was diluted four times with PBS (pH 7.4). The oxida-
tion was initiated by the addition of 100 WM CuSO4. This condition
was found to be suitable to oxidize the plasma within the time period
of 6 h. In another set of experiments, quercetin at concentrations
given in the ¢gure legend was added externally to control plasma
5 min before initiation of the oxidation with copper ion. The progress
of plasma oxidation was monitored by the measurement of cholesteryl
ester hydroperoxides (CE-OOH) and consumption of plasma K-toco-
pherol. The procedures for the determination of CE-OOH and K-
tocopherol in the plasma were described elsewhere [21].
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Fig. 1. Typical chromatogram of HPLC analysis of rat plasma extracts after oral administration of quercetin. A: The extracts without enzy-
matic hydrolysis. B: The extracts with hydrolysis by sulfatase H-5. Peaks I and II were identi¢ed as quercetin and isorhamnetin, respectively.
The plasma extracts were obtained from the 2 h after oral administration of propylene glycol solution of quercetin (2 mg/200 g body weight).
The eluting solvent for the HPLC analysis was composed of methanol/water/acetic acid (45/53/2, v/v/v). Other analytical conditions were the
same as those described in Section 2.
Table 1
Micromolar concentration of quercetin metabolites in rat plasma after intragastric adminstration of quercetin at two dose levels to rats
Time after adminstration
Conjugates 1 h 6 h
Dose 2 mga Quercetin (WM) Isorhamnetin (WM) Quercetin (WM) Isorhamnetin (WM)
Free 0 0 0 0
Sulfate 0.38 0 0 0
Glucuronide 6.14 0 1.33 0
Sulfoglucuronide 3.13 4.22 2.88 4.88
Total 9.64 4.22 4.21 4.88
Dose 10 mga Quercetin (WM) Isorhamnetin (WM) Quercetin (WM) Isorhamnetin (WM)
Free 0 0 0 0
Sulfate 10.4 0 0.4 0
Glucuronide 14.0 0 1.03 2.44
Sulfoglucuronide 44.6 20.4 18.0 13.56
Total 69.0 20.4 19.3 16.00
aDose: mg of free quercetin/200 g of rat body weight.
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3. Results and discussion
Quercetin dissolved in propylene glycol was administered
by intragastric intubation to fasted Wistar male rats at two
di¡erent dose levels, that is, 2 and 10 mg/200 g of body
weight. Fig. 1 shows the typical chromatogram of the plasma
extracts obtained from quercetin administered rats. After en-
zymatic hydrolysis, two new peaks appeared in the chromato-
gram and were veri¢ed to be free quercetin and its 3P-O-meth-
ylated form (isorhamnetin) by comparison with the retention
time of respective external standards. In addition, mass spec-
trometry showed an [M+1] at m/z 303 for the ¢rst peak in
the chromatogram, corresponding to the [M+1] of standard
quercetin, and an [M+1] at 317 for the second peak, corre-
sponding to the [M+1] of standard isorhamnetin, respec-
tively.
Plasma from four rats of each group was pooled in order to
minimize the variation in the metabolite levels due to individ-
ual di¡erences of absorption. Quercetin or isorhamnetin con-
tent after incubation with glucuronidase and sulfatase type
VIII was assumed to be the amount of glucuronide conjugates
and sulfate conjugates, respectively. The amount released by
the incubation with sulfatase type H-5 minus the amount
released by the glucuronidase and sulfatase type VIII treat-
ment was de¢ned as the amount of sulfoglucuronide conju-
gates. Table 1 shows the pooled plasma level of quercetin
metabolites determined 1 and 6 h after administration. No
free quercetin nor free isorhamnetin could be observed. One
h after administration of 2 mg quercetin, 13.86 WM of total
metabolites were found in the plasma pool, in which 70%
(9.64 WM) distributed as non-methylated quercetin metabo-
lites. The level of total metabolites decreased to 9.09 WM after
6 h, while the level of methylated form was unchanged. Ad-
ministration of 10 mg quercetin enhanced the total metabo-
lites level to 89.4 and 35.3 WM after 1 and 6 h respectively
(6.4- and 3.9-fold compared to 2 mg administration). No
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Fig. 2. Copper ion-induced lipid peroxidation of rat plasma ob-
tained from 1 h after administration of propylene glycol (control;
open symbols) or quercetin solution (closed symbols), 2 mg (R) or
10 mg (F)/200 g body weight. Accumulation of CE-OOH (A) and
consumption of K-tocopherol (B). Plasma from four rats of each
group was pooled, diluted four times with PBS and incubated with
100 WM CuSO4 at 37‡C for up to 6 h. The concentration of K-toco-
pherol in the incubation system was 4.35 WM and data were percen-
tages of the initial concentration.
Fig. 3. Copper ion-induced lipid peroxidation of rat plasma ob-
tained from 6 h after administration of propylene glycol (control;
open symbols) or quercetin solution (closed symbols), 2 mg (R) or
10 mg (F)/200 g body weight. Accumulation of CE-OOH (A) and
consumption of K-tocopherol (B). Plasma from four rats of each
group was pooled, diluted four times with PBS and incubated with
100 WM CuSO4 at 37‡C for up to 6 h. The concentration of K-toco-
pherol in the incubation system was 4.35 WM and data were percen-
tages of the initial concentration.
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quercetin metabolites were detected in the plasma from con-
trol rats.
The antioxidative activity of quercetin metabolites was ex-
amined by ex vivo incubation of the plasma with copper ion.
Fig. 2 shows the accumulation of CE-OOH (Fig. 2A) and
consumption of plasma K-tocopherol (Fig. 2B) in the plasma
from rat 1 h after administration of quercetin. An apparent
lag phase was observed in the ¢rst 2 h of incubation in the
case of CE-OOH accumulation. Both plasma after adminis-
tration of 2 mg quercetin and 10 mg quercetin showed a slight
but consistent lower level of CE-OOH and lower consumption
of K-tocopherol than control plasma. Quercetin administered
at 10 mg to rats increased the plasma resistance against cop-
per ion-induced oxidation as compared with the case of 2 mg
administration. As the ¢nal metabolite levels in the pooled
plasma were 13.9 and 89.4 WM for 2 mg quercetin and
10 mg quercetin administration, a dose-dependent inhibition
was observed in the amount of administered quercetin.
The same phenomena were observed in the oxidative resist-
ance of the rat plasma obtained after 6 h administration of
quercetin (Fig. 3A, B). The ¢nal metabolite levels in the
pooled plasma after 6 h administration was 9.1 WM and
35.3 WM for 2 mg and 10 mg quercetin administration, re-
spectively. The oxidation rate of plasma after 6 h of propylene
glycol (control), indicated by the increase of CE-OOH level,
was higher than that after 1 h. Since the animals were already
12^15 h fasted, additional 6 h of experimental period might be
signi¢cant to modify the level of other metabolites in plasma.
It is well known that the circulating levels of ketone bodies
(acetoacetate and L-hydroxybutyrate) and free fatty acids rise
during prolonged starvation [22]. Thus, the enhanced level of
free fatty acids may be responsible for increasing plasma ox-
idizability, but an in£uence of other components cannot be
excluded.
The antioxidant activity of free quercetin was con¢rmed in
our experimental model. In vitro addition of free quercetin to
the control plasma after 6 h administration of propylene gly-
col inhibited the copper ion-induced CE-OOH formation (Fig.
4) in a dose-dependent manner from 4 to 80 WM. By compar-
ing this result with those from the result of ex vivo experiment
(Fig. 3A), it can be concluded that some conjugated metabo-
lites of quercetin can inhibit copper ion-induced plasma per-
oxidation, similarly to free quercetin. Antioxidant activity of
quercetin is attributed to chelating and/or free radical-scav-
enging property of phenolic hydrogens in its structure [5].
Some phenolic hydrogens responsible for the antioxidant ac-
tivity is likely to remain during the process of metabolic con-
version. Thus, quercetin possesses an antioxidative activity
against copper ion-induced peroxidation of plasma lipids
even after absorption and metabolic conversion.
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Fig. 4. E¡ect of in vitro addition of quercetin at di¡erent concentra-
tions on the accumulation of CE-OOH in copper ion-induced lipid
peroxidation of rat plasma. Control plasma pool after 6 h adminis-
tration of propylene glycol was diluted four times with PBS and
oxidized with 100 WM CuSO4 at 37‡C for up to 6 h. Concentration
of quercetin added in the pooled plasma was as follows; a, none;
b, 8 WM; R, 40 WM; F, 80 WM.
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